AFFERA, INC.

affera-inc-logo

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.

#SimilarOrganizations #People #Financial #Website #More

AFFERA, INC.

Social Links:

Industry:
Biotechnology Health Care

Founded:
2015-01-01

Address:
Watertown, Massachusetts, United States

Country:
United States

Website Url:
http://www.affera.com

Total Employee:
11+

Status:
Active

Contact:
+1 857-304-4030

Email Addresses:
[email protected]

Total Funding:
5 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Mobile Non Scaleable Content HSTS


Similar Organizations

aer-therapeutics-logo

Aer Therapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

cognito-therapeutics-logo

Cognito Therapeutics

Cognito Therapeutics is a focused on discovering and developing new Alzheimer's treatments and preventive therapies.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

mirvie-logo

Mirvie

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

stratus-medical-logo

Stratus Medical

Stratusยฎ Medical's mission is to improve clinical outcomes for chronic pain patients by advancing RF technology for the treatment of pain.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

tridiuum-logo

Tridiuum

Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.

walden-biosciences-logo

Walden Biosciences

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.


Current Advisors List

leon-amariglio_image

Leon Amariglio Board Member @ Affera, Inc.
Board_member
2014-12-01

Current Employees Featured

doron-harlev_image

Doron Harlev
Doron Harlev Founder and CEO @ Affera, Inc.
Founder and CEO
2014-03-01

not_available_image

Bob Mest
Bob Mest Product Development Consultant @ Affera, Inc.
Product Development Consultant
2016-10-01

Founder


doron-harlev_image

Doron Harlev

Investors List

innogest-sgr_image

Innogest Capital

Innogest Capital investment in Venture Round - Affera, Inc.

norwich-ventures_image

Norwich Ventures

Norwich Ventures investment in Series A - Affera, Inc.

betaangels-management_image

BAMCAP

BAMCAP investment in Series A - Affera, Inc.

Official Site Inspections

http://www.affera.com Semrush global rank: 8.4 M Semrush visits lastest month: 537

  • Host name: 180.241.167.72.host.secureserver.net
  • IP address: 72.167.241.180
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Affera, Inc."

Affera, Inc. - Crunchbase Company Profile & Funding

Affera, Inc. may be growing as it has been acquired by a larger company, which typically indicates a positive valuation and a strategic fit for the acquirer's portfolio. The acquisition is aimed at โ€ฆSee details»

Afferaโ„ข Mapping System - Medtronic

The Afferaโ„ข mapping system with Prism-1 software is designed to automate, inform, and optimize the ablation procedure using innovative clinical tools. Skip to navigation Skip to main โ€ฆSee details»

Affera, Inc. - LinkedIn

Affera, Inc. | 7,574 followers on LinkedIn. Affera is a venture-backed medical device company founded by a seasoned team of leaders in the industry. We are developing an innovative system to treat ...See details»

Affera Company Profile 2024: Valuation, Investors, โ€ฆ

Nov 19, 2017 Affera General Information Description. Developer of a medical device designed to treat heart rhythm disorders. The company is engaged in the design and development of a novel medical system for the treatment of heart โ€ฆSee details»

Medtronic to Acquire Affera - Newswire

Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic โ€ฆSee details»

Medtronic completes acquisition of Affera - Aug 30, 2022

DUBLIN, Aug. 30, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Affera, Inc. This โ€ฆSee details»

Affera, Inc. - Funding, Financials, Valuation & Investors - Crunchbase

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. Search Crunchbase. ... How much funding has this โ€ฆSee details»

Affera, Inc. - Contacts, Employees, Board Members ... - Crunchbase

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. ... Solutions. Products. Resources. Pricing. Resources. Log โ€ฆSee details»

Affera Company Profile - Office Locations, Competitors, Revenue

Affera has 5 employees across 2 locations. See insights on Affera including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Medtronic completes acquisition of Affera - Newswire

Aug 30, 2022 In December 2021, Affera announced the commencement of the recently approved SPHERE Per-AF Trial, a U.S. Food and Drug Administration Investigational Device โ€ฆSee details»

Affera - Bain Capital Life Sciences

Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. Affera is developing a โ€ฆSee details»

Medtronic to Acquire Affera

Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will ... Affera is a medical technology company dedicated to delivering โ€ฆSee details»

Publications โ€“ Affera, Inc.

May 8, 2020 Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients. About Us Publications & NewsSee details»

Medtronic Announces Aquisition of Affera - Surgical Robotics โ€ฆ

Medtronic has announced that it has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company.Affera designs and โ€ฆSee details»

Affera Stock Price, Funding, Valuation, Revenue & Financial โ€ฆ

Jan 10, 2022 Funding, Valuation & Revenue. 4 Fundings. Affera has raised $75.68M over 4 rounds.. Affera's latest funding round was a Acquired for on January 10, 2022.. Affera's latest โ€ฆSee details»

Medtronic acquires Affera, Inc. - 2022-01-10 - Crunchbase

Jan 10, 2022 Affera, Inc. Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. Acquiring Organization: Medtronic โ€ฆSee details»

Medtronic completes acquisition of Affera - Cardiac Vascular News

DUBLIN, Aug. 30, 2022 /PRNewswire/ โ€” Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Affera, Inc. โ€ฆSee details»

Medtronic to Acquire Affera - Jan 10, 2022

Jan 10, 2022 "Bringing Affera into our organization, with our established footprint in the cardiac ablation space, will strengthen our ability to provide innovative therapies and enable Medtronic โ€ฆSee details»

News Archives โ€“ Affera, Inc.

May 12, 2020 Medtronic Completes Acquisition of Affera. by ncormierdesign | Aug 30, 2022 | News. Affera Announces First Patient Treated in SPHERE Per-AF IDE Trial. by โ€ฆSee details»

linkstock.net © 2022. All rights reserved